Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 1/20 | 0.48 |
| ▸ | CNR1 | P21554 | 4/20 | 0.47 |
| ▸ | CNR2 | P34972 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | PDE4B | Q07343 | 3/20 | 0.44 |
| ▸ | PDE4A | P27815 | 2/20 | 0.44 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.44 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.42 |
| ▸ | RXRA | P19793 | 1/20 | 0.40 |
| ▸ | RXRB | P28702 | 1/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL200188 | 0.82 | BACE1 (0.49) | BACE1ALDH1A1HPGDHSD17B10PDE4B | |
| SCHEMBL8900064 | 0.81 | BACE1 (0.47) | BACE1ALDH1A1HPGDHSD17B10PDE4B | |
| SCHEMBL13454410 | 0.81 | ALDH1A1 (0.57) | BACE1CNR1CNR2ALDH1A1HPGD | |
| SCHEMBL3418225 | 0.79 | BACE1 (0.56) | BACE1CNR1CNR2ALDH1A1HPGD | |
| SCHEMBL3624278 | 0.78 | BACE1 (0.43) | BACE1CNR1CNR2ALDH1A1HPGD | |
| SCHEMBL17500060 | 0.78 | ESR2 (0.47) | BACE1CNR1CNR2PDE4BALOX5 | |
| SCHEMBL15853188 | 0.76 | NPC1 (0.37) | ALDH1A1HPGDRXRARXRB | |
| SCHEMBL6320034 | 0.76 | CYP1A2 (0.53) | BACE1ALOX5 | |
| SCHEMBL7710060 | 0.76 | CNR1 (0.46) | BACE1CNR1CNR2ALDH1A1HPGD | |
| SCHEMBL23960860 | 0.75 | KIF11 (0.54) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1554293-B1 | BIS-CHELATING LIGAND AND USE THEREOF IN CARBONYLATION PROCESSES | UNION CARBIDE CHEM PLASTIC (US) | 2008-03-12 | — | — | EP | disclosed |
| US-7294729-B2 | Bis-chelating ligand and use thereof in carbonylation processes | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 2007-11-13 | — | — | US | disclosed |
| US-20060058557-A1 | Bis-chelating ligand and use thereof in carbonylation processes | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY LLC | 2006-03-16 | — | — | US | disclosed |
| EP-1554293-A1 | BIS-CHELATING LIGAND AND USE THEREOF IN CARBONYLATION PROCESSES | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 2005-07-20 | — | — | EP | disclosed |
| WO-2004035595-A1 | BIS-CHELATING LIGAND AND USE THEREOF IN CARBONYLATION PROCESSES | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 2004-04-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060058557-A1 | Bis-chelating ligand and use thereof in carbonylation processes | CBR1, CBR3, AR | BACE1 3716/4885CNR1 54/4885CNR2 58/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.